ERAP2 and pancreatic neoplasm: Notably, inhibiting ERAP2 through knockdown techniques not only suppressed tumor growth but also augmented the efficacy of gemcitabine, frontline chemotherapy for pancreatic cancer, inhibiting cancer cell proliferation, migration, and invasion.